- Home
- HOLOW vs GRMLW Comparison
HOLOW vs GRMLW Comparison
Compare HOLOW & GRMLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOLOW | GRMLW |
|---|---|---|
| Founded | N/A | N/A |
| Country | China | United States |
| Employees | 64 | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | HOLOW | GRMLW |
|---|---|---|
| Price | $0.09 | $0.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 9.9K | 7.2K |
| Earning Date | 03-14-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,242,196.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 326.95 | N/A |
| 52 Week Low | $0.07 | $0.10 |
| 52 Week High | $0.23 | $0.17 |
Technical Indicators
Market Signals| Indicator | HOLOW | GRMLW |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 66.37 |
| Support Level | $0.08 | $0.10 |
| Resistance Level | $0.11 | $0.17 |
| Average True Range (ATR) | 0.01 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 97.87 |
Price Performance
Historical ComparisonAbout HOLOW MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.
About GRMLW Greenland Mines Ltd Warrant
Greenland Mines Ltd operates in two divisions: (1) Natural Resources, focused on the exploration and development of the Skaergaard Project in Southeast Greenland, an undeveloped palladium, gold, and platinum deposit; and 2) Cell and Gene Therapy, which focuses on the development of biologic, cell, and gene therapies for neurodegenerative and age-related disorders, including Alzheimer's, amyotrophic lateral sclerosis (ALS), Parkinson's, and related conditions, targeting areas of high unmet medical need.